dc.contributor | Hospital General de Granollers |
dc.contributor.author | Marcé, Silvia |
dc.contributor.author | Xicoy, Blanca |
dc.contributor.author | García, Olga |
dc.contributor.author | Cabezón, Marta |
dc.contributor.author | Estrada, Natalia |
dc.contributor.author | Vélez, Patricia |
dc.contributor.author | Cortes, Montse |
dc.date.accessioned | 2021-11-11T12:17:47Z |
dc.date.available | 2021-11-11T12:17:47Z |
dc.date.issued | 2021-07-16 |
dc.identifier.citation | Marcé S, Xicoy B, García O, Cabezón M, Estrada N, Vélez P, et al. Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib. J Clin Med. 2021 Jul 16;10(14):3146. |
dc.identifier.issn | 2077-0383 |
dc.identifier.uri | https://hdl.handle.net/11351/6532 |
dc.description | Leucèmia mieloide crònica; Transcripcions BCR-ABL1; Resposta a imatinib |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Journal of Clinical Medicine;10(14) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Leucèmia mieloide crònica |
dc.subject | Imatinib |
dc.subject | Anàlisi de supervivència (Biometria) |
dc.subject.mesh | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
dc.subject.mesh | Imatinib Mesylate |
dc.subject.mesh | Survival Analysis |
dc.title | Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/jcm10143146 |
dc.subject.decs | leucemia mielogenosa crónica BCR-ABL positiva |
dc.subject.decs | mesilato de imatinib |
dc.subject.decs | análisis de supervivencia |
dc.relation.publishversion | https://doi.org/10.3390/jcm10143146 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Marcé S, Xicoy B, García O, Cabezón M, Estrada N] Myeloid Neoplasms Group, Hematology Department, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain. [Vélez P] Hematology Department, ICO Hospitalet-Hospital Duran y Reynals, l’Hospitalet de Llobregat, Spain. [Cortés M] Hospital General de Granollers, Granollers, Spain |
dc.identifier.pmid | 34300312 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |